Paul is an experienced physician executive who currently oversees reimbursement and regulatory affairs for ArteraAI. Paul has wide range of leadership experience roles within the healthcare industry at the intersection of business and health policy. Paul completed residency at Harvard Medical School’s Department of Physical Medicine and Rehabilitation at Spaulding Rehabilitation Hospital where he initially worked as an attending physician after completing residency. In this time in academia, Paul authored and coauthored numerous articles on health policy and healthcare quality measurement. Having a greater interest in business than academia, Paul decided to strike out on his own, leading him to move to Maine to start his own medical practice. In this role Paul not only continued to provide high quality patient care as part of his practice, but also he was a appointed to a leadership role as the associate medical director of a 90 bed rehabilitation hospital. In his time there he developed a data driven strategy to improve patient satisfaction within the hospital, and he worked to reduce unnecessary costs. Paul was then hired by a Medicare Administrative Contractor to the role of chief medical officer to assist with post-acute care oversight under the Medicare program, where he was quickly recruited to help manage the MolDX program, and appointed to be the Director of Clinical Science under MolDX. While working for Palmetto, Paul continued his work in both roles. Paul then gained further medical device experience when he joined McDermott+ Consulting as a Vice President focusing on market access consulting. Paul advised laboratories, investors, and medical device manufacturers. At McDermott+ Consulting, Paul advised numerous medical AI companies leading to his initial serious experiences with AI in medicine. Paul came to appreciate of the potential of AI to improve patient outcomes in this role, but at the same time he also witnessed the challenges of creating AI that is useful in clinical practice. Paul’s enthusiasm to join ArteraAI came from seeing company founders that clearly understood how to apply AI for real world clinical problem solving.